1.
Clin Exp Dermatol
; 47(11): 2043-2045, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35906074
RESUMO
Pityriasis rubra pilaris (PRP) is a rare, scaly, keratotic inflammatory skin disease characterized by red scaly patches, keratosis papules, palmoplantar keratoderma and scaling of the scalp. In severe cases, ectropion of the eyelid may occur, and erythroderma may further develop. Recently, it has been reported that secukinumab, a monoclonal anti-interleukin-17A antibody, has certain efficacy in the treatment of PRP. Herein, we report a 3-year-old Chinese boy with severe Type III (classic juvenile) PRP who was successfully treated with secukinumab alone.
Assuntos
Ceratodermia Palmar e Plantar , Pitiríase Rubra Pilar , Humanos , Masculino , Pré-Escolar , Pitiríase Rubra Pilar/tratamento farmacológico , Anticorpos Monoclonais Humanizados/uso terapêutico , Pele
2.
Oral Oncol
; 121: 105303, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33933346